High-dose chemotherapy followed by autologous stem-cell transplantation versus non-myeloablative consolidation in primary CNS lymphoma (MATRix/IELSG43): a randomised phase 3 trial

Authors:

Abstract
No abstract available
Funding Information
  • RIEMSER Pharma
  • Swiss Cancer Research Foundation
  • Bundesministerium für Forschung, Technologie und Raumfahrt (01KG1207)

This publication has 30 references indexed in Scilit: